0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

Update: Cutaneous Leishmaniasis in U.S. Military Personnel—Southwest/Central Asia, 2002-2004 FREE

JAMA. 2004;291(18):2188. doi:10.1001/jama.291.18.2188.
Text Size: A A A
Published online

UPDATE: CUTANEOUS LEISHMANIASIS IN U.S. MILITARY PERSONNEL—SOUTHWEST/CENTRAL ASIA, 2002-2004

MMWR. 2004;53:264-265

1 figure omitted

Cutaneous leishmaniasis (CL) is a sand fly–borne parasitic infection. Preliminary data about cases of CL in military personnel deployed to three countries (Afghanistan, Iraq, and Kuwait) in Southwest/Central Asia have been published previously.1 During August 2002–February 2004, Department of Defense (DoD) staff identified 522 parasitologically confirmed cases of CL in military personnel. Leishmania major was the etiologic agent for all 176 cases for which species data, obtained by isoenzyme electrophoresis of cultured parasites, are available. This update focuses on the 361 cases (69% of 522) in patients whose demographic data were collected systematically under treatment protocols for therapy with the pentavalent antimonial compound sodium stibogluconate (Pentostam®; GlaxoSmithKline, United Kingdom) at Walter Reed Army Medical Center, District of Columbia.1 U.S. health-care providers should consider CL in persons with persistent skin lesions who were deployed to Southwest/Central Asia or who were in other areas where leishmaniasis is endemic.

Of the 361 patients with CL, 352 (98%) were male; 274 (76%) were non-Hispanic white, 54 (15%) were non-Hispanic black, and 25 (7%) were Hispanic. The median age was 25 years (range: 18-57 years). On the basis of the patients' deployment histories, all but four of the patients probably were infected in Iraq, notably in areas near the Iraq-Syria border (e.g., Tall Afar) and the Iraq-Iran border (e.g., Balad Ruz, Kanaquin, Mandali, and Tursaq). The patients represented multiple branches of the U.S. military, including the Active Force, Reserve, and National Guard components of the Army, Air Force, and Marine Corps; the majority of the patients were in the Active Force component of the Army. Self-reported dates of onset of skin lesions ranged from May 2002 to January 2004, with 274 (78% of 350) occurring during August-November 2003, including 169 (48% of 350) during September-October.

DoD is implementing measures to decrease the risk for CL among U.S. military personnel in Southwest/Central Asia and to expedite detection and treatment of cases of CL. The measures include (1) improving living conditions for deployed personnel; (2) heightening awareness that leishmaniasis is endemic in this region (e.g., through publicity about cases of CL in U.S. military personnel and pre- and postdeployment briefings about leishmaniasis); (3) emphasizing the importance of deployed personnel using personal protective measures (e.g., using permethrin-treated clothing and bed nets or other barriers to sand flies, minimizing the amount of exposed skin, and applying insect repellent containing 30%-35% DEET to exposed skin, especially from dusk through dawn); and (4) enhancing vector-control activities.

Persons deployed previously to Southwest/Central Asia who have questions about their general health or leishmaniasis may contact DoD's Deployment Health Clinical Center, telephone 866-559-1627 or at http://www.pdhealth.mil. For evaluation, treatment, and referral of military health-care beneficiaries with suspected or confirmed cases of leishmaniasis, clinicians should contact the Infectious Disease Service of either Walter Reed Army Medical Center (District of Columbia), telephone 202-782-1663/8691, or Brooke Army Medical Center (San Antonio, Texas), telephone 210-916-5554/1286. Diagnostic support can be obtained by contacting the director of the leishmaniasis diagnostic laboratory at Walter Reed Army Institute of Research (Silver Spring, Maryland), telephone 301-319-9956.

Reported by:

N Aronson, MD, Uniformed Svcs Univ of the Health Sciences, Bethesda; M Ananthakrishnan, MD, W Bernstein, MD, L Hochberg, M Marovich, MD, C Ockenhouse, MD, I Yoon, MD, P Weina, MD, Walter Reed Army Institute of Research, Silver Spring, Maryland. P Benson, MD, J Fischer, MD, D Hack, MD, C Hawkes, MD, M Polhemus, MD, G Wortmann, MD, Walter Reed Army Medical Center; P McEvoy, MD, R Neafie, MA, Armed Forces Institute of Pathology, District of Columbia. R Defraites, MD, Office of the Surgeon General of the Army, Alexandria, Virginia. BL Herwaldt, MD, Div of Parasitic Diseases, National Center for Infectious Diseases, CDC.

Acknowledgments

This report is based in part on data provided by L Figuero, E Fleming, MS, J Mendez, J Tally, Walter Reed Army Institute of Research, Silver Spring, Maryland, and staff of the Infectious Disease Svc, Walter Reed Army Medical Center, District of Columbia.

References
CDC.  Cutaneous leishmaniasis in U.S. military personnel—Southwest/Central Asia, 2002-2003.  MMWR.2003;52:1009-12.

Figures

Tables

References

CDC.  Cutaneous leishmaniasis in U.S. military personnel—Southwest/Central Asia, 2002-2003.  MMWR.2003;52:1009-12.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles